Global Metronidazole Market research

Metronidazole Comprehensive Study by Type (Metronidazole Tablets, Metronidazole Capsule, Metronidazole Injection, Others), Application (Anaerobic Bacterial Infections, Sexually Transmitted Disease, Bacterial Vaginosis, Colorectal Surgical Infections, Others), Distribution Chanel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), End-User (Hospitals, Clinics, Surgical Centers, Others) Players and Region - Global Market Outlook to 2030

Metronidazole Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 7.8%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Metronidazole Market Scope
Metronidazole is an antibiotic, which is used to treat a wide variety of infections of the vagina, stomach or intestines, liver, skin, joints, liver, respiratory tract, brain and heart. It belongs to a class of drugs called nitroimidazole antimicrobials. The drugs in this class work in a similar way and used to treat similar conditions. Metronidazole works by stopping the growth of certain bacteria and parasites.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
Key Companies ProfiledPfizer (United States), Alembic Pharmaceuticals Ltd (India), Watson Pharmaceuticals, Inc. (United States), Cadila Healthcare (India), Medline Industries, Inc. (United States), Lupin Limited (India), Perrigo (Ireland), Hongyuan Pharmaceutical Co.,Ltd. (China) and Aurobindo Pharma (India)
CAGR7.8%


Research Analyst at AMA estimates that United States and Indian Players will contribute to the maximum growth of Global Metronidazole market throughout the predicted period.

Pfizer (United States), Alembic Pharmaceuticals Ltd (India), Watson Pharmaceuticals, Inc. (United States), Cadila Healthcare (India), Medline Industries, Inc. (United States), Lupin Limited (India), Perrigo (Ireland), Hongyuan Pharmaceutical Co.,Ltd. (China) and Aurobindo Pharma (India) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Kopran Limited (India) and Polpharma API (Poland).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Metronidazole market by Type , by Application (Anaerobic Bacterial Infections, Sexually Transmitted Disease, Bacterial Vaginosis, Colorectal Surgical Infections and Others) and Region with country level break-up.

On the basis of geography, the market of Metronidazole has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2023.

In July 2019, Perrigo Company plc announced its product development partner received final approval from the U.S. Food and Drug Administration for its AB-rated Abbreviated New Drug Application (“ANDA”) referencing Metrogel-Vaginal (metronidazole vaginal gel 0.75%).


Influencing Trend:
Technological Advancements in the Field Of Medical Science and Research and Development to Boost the Market Demand

Market Growth Drivers:
Increase in Prevalence of Bacterial Infections, Growing Awareness about Healthy Life among People and Increase in Healthcare Expenditure

Restraints:
Overdose May Cause Serious Symptoms

Opportunities:
Development of Healthcare Infrastructure in Emerging Economies and Rise in the Online Pharmacies

Key Target Audience
Metronidazole Manufacturers, Research Professionals, Emerging Companies, Distributors, Government Body & Associations and End-user

Report Objectives / Segmentation Covered

By Type
  • Metronidazole Tablets
  • Metronidazole Capsule
  • Metronidazole Injection
  • Others
By Application
  • Anaerobic Bacterial Infections
  • Sexually Transmitted Disease
  • Bacterial Vaginosis
  • Colorectal Surgical Infections
  • Others
By Distribution Chanel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

By End-User
  • Hospitals
  • Clinics
  • Surgical Centers
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in Prevalence of Bacterial Infections
      • 3.2.2. Growing Awareness about Healthy Life among People
      • 3.2.3. Increase in Healthcare Expenditure
    • 3.3. Market Trends
      • 3.3.1. Technological Advancements in the Field Of Medical Science
      • 3.3.2. Research and Development to Boost the Market Demand
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Metronidazole, by Type, Application, Distribution Chanel, End-User and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Metronidazole (Value)
      • 5.2.1. Global Metronidazole by: Type (Value)
        • 5.2.1.1. Metronidazole Tablets
        • 5.2.1.2. Metronidazole Capsule
        • 5.2.1.3. Metronidazole Injection
        • 5.2.1.4. Others
      • 5.2.2. Global Metronidazole by: Application (Value)
        • 5.2.2.1. Anaerobic Bacterial Infections
        • 5.2.2.2. Sexually Transmitted Disease
        • 5.2.2.3. Bacterial Vaginosis
        • 5.2.2.4. Colorectal Surgical Infections
        • 5.2.2.5. Others
      • 5.2.3. Global Metronidazole by: Distribution Chanel (Value)
        • 5.2.3.1. Hospital Pharmacy
        • 5.2.3.2. Retail Pharmacy
        • 5.2.3.3. Online Pharmacy
        • 5.2.3.4. Others
      • 5.2.4. Global Metronidazole by: End-User (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Clinics
        • 5.2.4.3. Surgical Centers
        • 5.2.4.4. Others
      • 5.2.5. Global Metronidazole Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Metronidazole: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Pfizer (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Alembic Pharmaceuticals Ltd (India)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Watson Pharmaceuticals, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Cadila Healthcare (India)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Medline Industries, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Lupin Limited (India)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Perrigo (Ireland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Hongyuan Pharmaceutical Co.,Ltd. (China)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Aurobindo Pharma (India)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Metronidazole Sale, by Type, Application, Distribution Chanel, End-User and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Metronidazole (Value)
      • 7.2.1. Global Metronidazole by: Type (Value)
        • 7.2.1.1. Metronidazole Tablets
        • 7.2.1.2. Metronidazole Capsule
        • 7.2.1.3. Metronidazole Injection
        • 7.2.1.4. Others
      • 7.2.2. Global Metronidazole by: Application (Value)
        • 7.2.2.1. Anaerobic Bacterial Infections
        • 7.2.2.2. Sexually Transmitted Disease
        • 7.2.2.3. Bacterial Vaginosis
        • 7.2.2.4. Colorectal Surgical Infections
        • 7.2.2.5. Others
      • 7.2.3. Global Metronidazole by: Distribution Chanel (Value)
        • 7.2.3.1. Hospital Pharmacy
        • 7.2.3.2. Retail Pharmacy
        • 7.2.3.3. Online Pharmacy
        • 7.2.3.4. Others
      • 7.2.4. Global Metronidazole by: End-User (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Clinics
        • 7.2.4.3. Surgical Centers
        • 7.2.4.4. Others
      • 7.2.5. Global Metronidazole Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Metronidazole: by Type(USD Million)
  • Table 2. Metronidazole Metronidazole Tablets , by Region USD Million (2018-2023)
  • Table 3. Metronidazole Metronidazole Capsule , by Region USD Million (2018-2023)
  • Table 4. Metronidazole Metronidazole Injection , by Region USD Million (2018-2023)
  • Table 5. Metronidazole Others , by Region USD Million (2018-2023)
  • Table 6. Metronidazole: by Application(USD Million)
  • Table 7. Metronidazole Anaerobic Bacterial Infections , by Region USD Million (2018-2023)
  • Table 8. Metronidazole Sexually Transmitted Disease , by Region USD Million (2018-2023)
  • Table 9. Metronidazole Bacterial Vaginosis , by Region USD Million (2018-2023)
  • Table 10. Metronidazole Colorectal Surgical Infections , by Region USD Million (2018-2023)
  • Table 11. Metronidazole Others , by Region USD Million (2018-2023)
  • Table 12. Metronidazole: by Distribution Chanel(USD Million)
  • Table 13. Metronidazole Hospital Pharmacy , by Region USD Million (2018-2023)
  • Table 14. Metronidazole Retail Pharmacy , by Region USD Million (2018-2023)
  • Table 15. Metronidazole Online Pharmacy , by Region USD Million (2018-2023)
  • Table 16. Metronidazole Others , by Region USD Million (2018-2023)
  • Table 17. Metronidazole: by End-User(USD Million)
  • Table 18. Metronidazole Hospitals , by Region USD Million (2018-2023)
  • Table 19. Metronidazole Clinics , by Region USD Million (2018-2023)
  • Table 20. Metronidazole Surgical Centers , by Region USD Million (2018-2023)
  • Table 21. Metronidazole Others , by Region USD Million (2018-2023)
  • Table 22. South America Metronidazole, by Country USD Million (2018-2023)
  • Table 23. South America Metronidazole, by Type USD Million (2018-2023)
  • Table 24. South America Metronidazole, by Application USD Million (2018-2023)
  • Table 25. South America Metronidazole, by Distribution Chanel USD Million (2018-2023)
  • Table 26. South America Metronidazole, by End-User USD Million (2018-2023)
  • Table 27. Brazil Metronidazole, by Type USD Million (2018-2023)
  • Table 28. Brazil Metronidazole, by Application USD Million (2018-2023)
  • Table 29. Brazil Metronidazole, by Distribution Chanel USD Million (2018-2023)
  • Table 30. Brazil Metronidazole, by End-User USD Million (2018-2023)
  • Table 31. Argentina Metronidazole, by Type USD Million (2018-2023)
  • Table 32. Argentina Metronidazole, by Application USD Million (2018-2023)
  • Table 33. Argentina Metronidazole, by Distribution Chanel USD Million (2018-2023)
  • Table 34. Argentina Metronidazole, by End-User USD Million (2018-2023)
  • Table 35. Rest of South America Metronidazole, by Type USD Million (2018-2023)
  • Table 36. Rest of South America Metronidazole, by Application USD Million (2018-2023)
  • Table 37. Rest of South America Metronidazole, by Distribution Chanel USD Million (2018-2023)
  • Table 38. Rest of South America Metronidazole, by End-User USD Million (2018-2023)
  • Table 39. Asia Pacific Metronidazole, by Country USD Million (2018-2023)
  • Table 40. Asia Pacific Metronidazole, by Type USD Million (2018-2023)
  • Table 41. Asia Pacific Metronidazole, by Application USD Million (2018-2023)
  • Table 42. Asia Pacific Metronidazole, by Distribution Chanel USD Million (2018-2023)
  • Table 43. Asia Pacific Metronidazole, by End-User USD Million (2018-2023)
  • Table 44. China Metronidazole, by Type USD Million (2018-2023)
  • Table 45. China Metronidazole, by Application USD Million (2018-2023)
  • Table 46. China Metronidazole, by Distribution Chanel USD Million (2018-2023)
  • Table 47. China Metronidazole, by End-User USD Million (2018-2023)
  • Table 48. Japan Metronidazole, by Type USD Million (2018-2023)
  • Table 49. Japan Metronidazole, by Application USD Million (2018-2023)
  • Table 50. Japan Metronidazole, by Distribution Chanel USD Million (2018-2023)
  • Table 51. Japan Metronidazole, by End-User USD Million (2018-2023)
  • Table 52. India Metronidazole, by Type USD Million (2018-2023)
  • Table 53. India Metronidazole, by Application USD Million (2018-2023)
  • Table 54. India Metronidazole, by Distribution Chanel USD Million (2018-2023)
  • Table 55. India Metronidazole, by End-User USD Million (2018-2023)
  • Table 56. South Korea Metronidazole, by Type USD Million (2018-2023)
  • Table 57. South Korea Metronidazole, by Application USD Million (2018-2023)
  • Table 58. South Korea Metronidazole, by Distribution Chanel USD Million (2018-2023)
  • Table 59. South Korea Metronidazole, by End-User USD Million (2018-2023)
  • Table 60. Taiwan Metronidazole, by Type USD Million (2018-2023)
  • Table 61. Taiwan Metronidazole, by Application USD Million (2018-2023)
  • Table 62. Taiwan Metronidazole, by Distribution Chanel USD Million (2018-2023)
  • Table 63. Taiwan Metronidazole, by End-User USD Million (2018-2023)
  • Table 64. Australia Metronidazole, by Type USD Million (2018-2023)
  • Table 65. Australia Metronidazole, by Application USD Million (2018-2023)
  • Table 66. Australia Metronidazole, by Distribution Chanel USD Million (2018-2023)
  • Table 67. Australia Metronidazole, by End-User USD Million (2018-2023)
  • Table 68. Rest of Asia-Pacific Metronidazole, by Type USD Million (2018-2023)
  • Table 69. Rest of Asia-Pacific Metronidazole, by Application USD Million (2018-2023)
  • Table 70. Rest of Asia-Pacific Metronidazole, by Distribution Chanel USD Million (2018-2023)
  • Table 71. Rest of Asia-Pacific Metronidazole, by End-User USD Million (2018-2023)
  • Table 72. Europe Metronidazole, by Country USD Million (2018-2023)
  • Table 73. Europe Metronidazole, by Type USD Million (2018-2023)
  • Table 74. Europe Metronidazole, by Application USD Million (2018-2023)
  • Table 75. Europe Metronidazole, by Distribution Chanel USD Million (2018-2023)
  • Table 76. Europe Metronidazole, by End-User USD Million (2018-2023)
  • Table 77. Germany Metronidazole, by Type USD Million (2018-2023)
  • Table 78. Germany Metronidazole, by Application USD Million (2018-2023)
  • Table 79. Germany Metronidazole, by Distribution Chanel USD Million (2018-2023)
  • Table 80. Germany Metronidazole, by End-User USD Million (2018-2023)
  • Table 81. France Metronidazole, by Type USD Million (2018-2023)
  • Table 82. France Metronidazole, by Application USD Million (2018-2023)
  • Table 83. France Metronidazole, by Distribution Chanel USD Million (2018-2023)
  • Table 84. France Metronidazole, by End-User USD Million (2018-2023)
  • Table 85. Italy Metronidazole, by Type USD Million (2018-2023)
  • Table 86. Italy Metronidazole, by Application USD Million (2018-2023)
  • Table 87. Italy Metronidazole, by Distribution Chanel USD Million (2018-2023)
  • Table 88. Italy Metronidazole, by End-User USD Million (2018-2023)
  • Table 89. United Kingdom Metronidazole, by Type USD Million (2018-2023)
  • Table 90. United Kingdom Metronidazole, by Application USD Million (2018-2023)
  • Table 91. United Kingdom Metronidazole, by Distribution Chanel USD Million (2018-2023)
  • Table 92. United Kingdom Metronidazole, by End-User USD Million (2018-2023)
  • Table 93. Netherlands Metronidazole, by Type USD Million (2018-2023)
  • Table 94. Netherlands Metronidazole, by Application USD Million (2018-2023)
  • Table 95. Netherlands Metronidazole, by Distribution Chanel USD Million (2018-2023)
  • Table 96. Netherlands Metronidazole, by End-User USD Million (2018-2023)
  • Table 97. Rest of Europe Metronidazole, by Type USD Million (2018-2023)
  • Table 98. Rest of Europe Metronidazole, by Application USD Million (2018-2023)
  • Table 99. Rest of Europe Metronidazole, by Distribution Chanel USD Million (2018-2023)
  • Table 100. Rest of Europe Metronidazole, by End-User USD Million (2018-2023)
  • Table 101. MEA Metronidazole, by Country USD Million (2018-2023)
  • Table 102. MEA Metronidazole, by Type USD Million (2018-2023)
  • Table 103. MEA Metronidazole, by Application USD Million (2018-2023)
  • Table 104. MEA Metronidazole, by Distribution Chanel USD Million (2018-2023)
  • Table 105. MEA Metronidazole, by End-User USD Million (2018-2023)
  • Table 106. Middle East Metronidazole, by Type USD Million (2018-2023)
  • Table 107. Middle East Metronidazole, by Application USD Million (2018-2023)
  • Table 108. Middle East Metronidazole, by Distribution Chanel USD Million (2018-2023)
  • Table 109. Middle East Metronidazole, by End-User USD Million (2018-2023)
  • Table 110. Africa Metronidazole, by Type USD Million (2018-2023)
  • Table 111. Africa Metronidazole, by Application USD Million (2018-2023)
  • Table 112. Africa Metronidazole, by Distribution Chanel USD Million (2018-2023)
  • Table 113. Africa Metronidazole, by End-User USD Million (2018-2023)
  • Table 114. North America Metronidazole, by Country USD Million (2018-2023)
  • Table 115. North America Metronidazole, by Type USD Million (2018-2023)
  • Table 116. North America Metronidazole, by Application USD Million (2018-2023)
  • Table 117. North America Metronidazole, by Distribution Chanel USD Million (2018-2023)
  • Table 118. North America Metronidazole, by End-User USD Million (2018-2023)
  • Table 119. United States Metronidazole, by Type USD Million (2018-2023)
  • Table 120. United States Metronidazole, by Application USD Million (2018-2023)
  • Table 121. United States Metronidazole, by Distribution Chanel USD Million (2018-2023)
  • Table 122. United States Metronidazole, by End-User USD Million (2018-2023)
  • Table 123. Canada Metronidazole, by Type USD Million (2018-2023)
  • Table 124. Canada Metronidazole, by Application USD Million (2018-2023)
  • Table 125. Canada Metronidazole, by Distribution Chanel USD Million (2018-2023)
  • Table 126. Canada Metronidazole, by End-User USD Million (2018-2023)
  • Table 127. Mexico Metronidazole, by Type USD Million (2018-2023)
  • Table 128. Mexico Metronidazole, by Application USD Million (2018-2023)
  • Table 129. Mexico Metronidazole, by Distribution Chanel USD Million (2018-2023)
  • Table 130. Mexico Metronidazole, by End-User USD Million (2018-2023)
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Metronidazole: by Type(USD Million)
  • Table 141. Metronidazole Metronidazole Tablets , by Region USD Million (2025-2030)
  • Table 142. Metronidazole Metronidazole Capsule , by Region USD Million (2025-2030)
  • Table 143. Metronidazole Metronidazole Injection , by Region USD Million (2025-2030)
  • Table 144. Metronidazole Others , by Region USD Million (2025-2030)
  • Table 145. Metronidazole: by Application(USD Million)
  • Table 146. Metronidazole Anaerobic Bacterial Infections , by Region USD Million (2025-2030)
  • Table 147. Metronidazole Sexually Transmitted Disease , by Region USD Million (2025-2030)
  • Table 148. Metronidazole Bacterial Vaginosis , by Region USD Million (2025-2030)
  • Table 149. Metronidazole Colorectal Surgical Infections , by Region USD Million (2025-2030)
  • Table 150. Metronidazole Others , by Region USD Million (2025-2030)
  • Table 151. Metronidazole: by Distribution Chanel(USD Million)
  • Table 152. Metronidazole Hospital Pharmacy , by Region USD Million (2025-2030)
  • Table 153. Metronidazole Retail Pharmacy , by Region USD Million (2025-2030)
  • Table 154. Metronidazole Online Pharmacy , by Region USD Million (2025-2030)
  • Table 155. Metronidazole Others , by Region USD Million (2025-2030)
  • Table 156. Metronidazole: by End-User(USD Million)
  • Table 157. Metronidazole Hospitals , by Region USD Million (2025-2030)
  • Table 158. Metronidazole Clinics , by Region USD Million (2025-2030)
  • Table 159. Metronidazole Surgical Centers , by Region USD Million (2025-2030)
  • Table 160. Metronidazole Others , by Region USD Million (2025-2030)
  • Table 161. South America Metronidazole, by Country USD Million (2025-2030)
  • Table 162. South America Metronidazole, by Type USD Million (2025-2030)
  • Table 163. South America Metronidazole, by Application USD Million (2025-2030)
  • Table 164. South America Metronidazole, by Distribution Chanel USD Million (2025-2030)
  • Table 165. South America Metronidazole, by End-User USD Million (2025-2030)
  • Table 166. Brazil Metronidazole, by Type USD Million (2025-2030)
  • Table 167. Brazil Metronidazole, by Application USD Million (2025-2030)
  • Table 168. Brazil Metronidazole, by Distribution Chanel USD Million (2025-2030)
  • Table 169. Brazil Metronidazole, by End-User USD Million (2025-2030)
  • Table 170. Argentina Metronidazole, by Type USD Million (2025-2030)
  • Table 171. Argentina Metronidazole, by Application USD Million (2025-2030)
  • Table 172. Argentina Metronidazole, by Distribution Chanel USD Million (2025-2030)
  • Table 173. Argentina Metronidazole, by End-User USD Million (2025-2030)
  • Table 174. Rest of South America Metronidazole, by Type USD Million (2025-2030)
  • Table 175. Rest of South America Metronidazole, by Application USD Million (2025-2030)
  • Table 176. Rest of South America Metronidazole, by Distribution Chanel USD Million (2025-2030)
  • Table 177. Rest of South America Metronidazole, by End-User USD Million (2025-2030)
  • Table 178. Asia Pacific Metronidazole, by Country USD Million (2025-2030)
  • Table 179. Asia Pacific Metronidazole, by Type USD Million (2025-2030)
  • Table 180. Asia Pacific Metronidazole, by Application USD Million (2025-2030)
  • Table 181. Asia Pacific Metronidazole, by Distribution Chanel USD Million (2025-2030)
  • Table 182. Asia Pacific Metronidazole, by End-User USD Million (2025-2030)
  • Table 183. China Metronidazole, by Type USD Million (2025-2030)
  • Table 184. China Metronidazole, by Application USD Million (2025-2030)
  • Table 185. China Metronidazole, by Distribution Chanel USD Million (2025-2030)
  • Table 186. China Metronidazole, by End-User USD Million (2025-2030)
  • Table 187. Japan Metronidazole, by Type USD Million (2025-2030)
  • Table 188. Japan Metronidazole, by Application USD Million (2025-2030)
  • Table 189. Japan Metronidazole, by Distribution Chanel USD Million (2025-2030)
  • Table 190. Japan Metronidazole, by End-User USD Million (2025-2030)
  • Table 191. India Metronidazole, by Type USD Million (2025-2030)
  • Table 192. India Metronidazole, by Application USD Million (2025-2030)
  • Table 193. India Metronidazole, by Distribution Chanel USD Million (2025-2030)
  • Table 194. India Metronidazole, by End-User USD Million (2025-2030)
  • Table 195. South Korea Metronidazole, by Type USD Million (2025-2030)
  • Table 196. South Korea Metronidazole, by Application USD Million (2025-2030)
  • Table 197. South Korea Metronidazole, by Distribution Chanel USD Million (2025-2030)
  • Table 198. South Korea Metronidazole, by End-User USD Million (2025-2030)
  • Table 199. Taiwan Metronidazole, by Type USD Million (2025-2030)
  • Table 200. Taiwan Metronidazole, by Application USD Million (2025-2030)
  • Table 201. Taiwan Metronidazole, by Distribution Chanel USD Million (2025-2030)
  • Table 202. Taiwan Metronidazole, by End-User USD Million (2025-2030)
  • Table 203. Australia Metronidazole, by Type USD Million (2025-2030)
  • Table 204. Australia Metronidazole, by Application USD Million (2025-2030)
  • Table 205. Australia Metronidazole, by Distribution Chanel USD Million (2025-2030)
  • Table 206. Australia Metronidazole, by End-User USD Million (2025-2030)
  • Table 207. Rest of Asia-Pacific Metronidazole, by Type USD Million (2025-2030)
  • Table 208. Rest of Asia-Pacific Metronidazole, by Application USD Million (2025-2030)
  • Table 209. Rest of Asia-Pacific Metronidazole, by Distribution Chanel USD Million (2025-2030)
  • Table 210. Rest of Asia-Pacific Metronidazole, by End-User USD Million (2025-2030)
  • Table 211. Europe Metronidazole, by Country USD Million (2025-2030)
  • Table 212. Europe Metronidazole, by Type USD Million (2025-2030)
  • Table 213. Europe Metronidazole, by Application USD Million (2025-2030)
  • Table 214. Europe Metronidazole, by Distribution Chanel USD Million (2025-2030)
  • Table 215. Europe Metronidazole, by End-User USD Million (2025-2030)
  • Table 216. Germany Metronidazole, by Type USD Million (2025-2030)
  • Table 217. Germany Metronidazole, by Application USD Million (2025-2030)
  • Table 218. Germany Metronidazole, by Distribution Chanel USD Million (2025-2030)
  • Table 219. Germany Metronidazole, by End-User USD Million (2025-2030)
  • Table 220. France Metronidazole, by Type USD Million (2025-2030)
  • Table 221. France Metronidazole, by Application USD Million (2025-2030)
  • Table 222. France Metronidazole, by Distribution Chanel USD Million (2025-2030)
  • Table 223. France Metronidazole, by End-User USD Million (2025-2030)
  • Table 224. Italy Metronidazole, by Type USD Million (2025-2030)
  • Table 225. Italy Metronidazole, by Application USD Million (2025-2030)
  • Table 226. Italy Metronidazole, by Distribution Chanel USD Million (2025-2030)
  • Table 227. Italy Metronidazole, by End-User USD Million (2025-2030)
  • Table 228. United Kingdom Metronidazole, by Type USD Million (2025-2030)
  • Table 229. United Kingdom Metronidazole, by Application USD Million (2025-2030)
  • Table 230. United Kingdom Metronidazole, by Distribution Chanel USD Million (2025-2030)
  • Table 231. United Kingdom Metronidazole, by End-User USD Million (2025-2030)
  • Table 232. Netherlands Metronidazole, by Type USD Million (2025-2030)
  • Table 233. Netherlands Metronidazole, by Application USD Million (2025-2030)
  • Table 234. Netherlands Metronidazole, by Distribution Chanel USD Million (2025-2030)
  • Table 235. Netherlands Metronidazole, by End-User USD Million (2025-2030)
  • Table 236. Rest of Europe Metronidazole, by Type USD Million (2025-2030)
  • Table 237. Rest of Europe Metronidazole, by Application USD Million (2025-2030)
  • Table 238. Rest of Europe Metronidazole, by Distribution Chanel USD Million (2025-2030)
  • Table 239. Rest of Europe Metronidazole, by End-User USD Million (2025-2030)
  • Table 240. MEA Metronidazole, by Country USD Million (2025-2030)
  • Table 241. MEA Metronidazole, by Type USD Million (2025-2030)
  • Table 242. MEA Metronidazole, by Application USD Million (2025-2030)
  • Table 243. MEA Metronidazole, by Distribution Chanel USD Million (2025-2030)
  • Table 244. MEA Metronidazole, by End-User USD Million (2025-2030)
  • Table 245. Middle East Metronidazole, by Type USD Million (2025-2030)
  • Table 246. Middle East Metronidazole, by Application USD Million (2025-2030)
  • Table 247. Middle East Metronidazole, by Distribution Chanel USD Million (2025-2030)
  • Table 248. Middle East Metronidazole, by End-User USD Million (2025-2030)
  • Table 249. Africa Metronidazole, by Type USD Million (2025-2030)
  • Table 250. Africa Metronidazole, by Application USD Million (2025-2030)
  • Table 251. Africa Metronidazole, by Distribution Chanel USD Million (2025-2030)
  • Table 252. Africa Metronidazole, by End-User USD Million (2025-2030)
  • Table 253. North America Metronidazole, by Country USD Million (2025-2030)
  • Table 254. North America Metronidazole, by Type USD Million (2025-2030)
  • Table 255. North America Metronidazole, by Application USD Million (2025-2030)
  • Table 256. North America Metronidazole, by Distribution Chanel USD Million (2025-2030)
  • Table 257. North America Metronidazole, by End-User USD Million (2025-2030)
  • Table 258. United States Metronidazole, by Type USD Million (2025-2030)
  • Table 259. United States Metronidazole, by Application USD Million (2025-2030)
  • Table 260. United States Metronidazole, by Distribution Chanel USD Million (2025-2030)
  • Table 261. United States Metronidazole, by End-User USD Million (2025-2030)
  • Table 262. Canada Metronidazole, by Type USD Million (2025-2030)
  • Table 263. Canada Metronidazole, by Application USD Million (2025-2030)
  • Table 264. Canada Metronidazole, by Distribution Chanel USD Million (2025-2030)
  • Table 265. Canada Metronidazole, by End-User USD Million (2025-2030)
  • Table 266. Mexico Metronidazole, by Type USD Million (2025-2030)
  • Table 267. Mexico Metronidazole, by Application USD Million (2025-2030)
  • Table 268. Mexico Metronidazole, by Distribution Chanel USD Million (2025-2030)
  • Table 269. Mexico Metronidazole, by End-User USD Million (2025-2030)
  • Table 270. Research Programs/Design for This Report
  • Table 271. Key Data Information from Secondary Sources
  • Table 272. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Metronidazole: by Type USD Million (2018-2023)
  • Figure 5. Global Metronidazole: by Application USD Million (2018-2023)
  • Figure 6. Global Metronidazole: by Distribution Chanel USD Million (2018-2023)
  • Figure 7. Global Metronidazole: by End-User USD Million (2018-2023)
  • Figure 8. South America Metronidazole Share (%), by Country
  • Figure 9. Asia Pacific Metronidazole Share (%), by Country
  • Figure 10. Europe Metronidazole Share (%), by Country
  • Figure 11. MEA Metronidazole Share (%), by Country
  • Figure 12. North America Metronidazole Share (%), by Country
  • Figure 13. Global Metronidazole share by Players 2023 (%)
  • Figure 14. Global Metronidazole share by Players (Top 3) 2023(%)
  • Figure 15. Global Metronidazole share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Pfizer (United States) Revenue, Net Income and Gross profit
  • Figure 18. Pfizer (United States) Revenue: by Geography 2023
  • Figure 19. Alembic Pharmaceuticals Ltd (India) Revenue, Net Income and Gross profit
  • Figure 20. Alembic Pharmaceuticals Ltd (India) Revenue: by Geography 2023
  • Figure 21. Watson Pharmaceuticals, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. Watson Pharmaceuticals, Inc. (United States) Revenue: by Geography 2023
  • Figure 23. Cadila Healthcare (India) Revenue, Net Income and Gross profit
  • Figure 24. Cadila Healthcare (India) Revenue: by Geography 2023
  • Figure 25. Medline Industries, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Medline Industries, Inc. (United States) Revenue: by Geography 2023
  • Figure 27. Lupin Limited (India) Revenue, Net Income and Gross profit
  • Figure 28. Lupin Limited (India) Revenue: by Geography 2023
  • Figure 29. Perrigo (Ireland) Revenue, Net Income and Gross profit
  • Figure 30. Perrigo (Ireland) Revenue: by Geography 2023
  • Figure 31. Hongyuan Pharmaceutical Co.,Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 32. Hongyuan Pharmaceutical Co.,Ltd. (China) Revenue: by Geography 2023
  • Figure 33. Aurobindo Pharma (India) Revenue, Net Income and Gross profit
  • Figure 34. Aurobindo Pharma (India) Revenue: by Geography 2023
  • Figure 35. Global Metronidazole: by Type USD Million (2025-2030)
  • Figure 36. Global Metronidazole: by Application USD Million (2025-2030)
  • Figure 37. Global Metronidazole: by Distribution Chanel USD Million (2025-2030)
  • Figure 38. Global Metronidazole: by End-User USD Million (2025-2030)
  • Figure 39. South America Metronidazole Share (%), by Country
  • Figure 40. Asia Pacific Metronidazole Share (%), by Country
  • Figure 41. Europe Metronidazole Share (%), by Country
  • Figure 42. MEA Metronidazole Share (%), by Country
  • Figure 43. North America Metronidazole Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Pfizer (United States)
  • Alembic Pharmaceuticals Ltd (India)
  • Watson Pharmaceuticals, Inc. (United States)
  • Cadila Healthcare (India)
  • Medline Industries, Inc. (United States)
  • Lupin Limited (India)
  • Perrigo (Ireland)
  • Hongyuan Pharmaceutical Co.,Ltd. (China)
  • Aurobindo Pharma (India)
Additional players considered in the study are as follows:
Kopran Limited (India) , Polpharma API (Poland)
Select User Access Type

Key Highlights of Report


Apr 2024 236 Pages 74 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Metronidazole Market research Quantitative research analysis
Global Metronidazole Market research Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Metronidazole Market are by type [Metronidazole Tablets, Metronidazole Capsule, Metronidazole Injection and Others], by end use application [Anaerobic Bacterial Infections, Sexually Transmitted Disease, Bacterial Vaginosis, Colorectal Surgical Infections and Others].
The Metronidazole Market is gaining popularity and expected to see strong valuation by 2030.
  • Increase in Prevalence of Bacterial Infections
  • Growing Awareness about Healthy Life among People
  • Increase in Healthcare Expenditure

Know More About Global Metronidazole Market research Report?

Have a Query? Click Here

Other Related Reports

Botox Comprehensive Study by Type (Botulinum Toxin Type A, Botulinum Toxin Type B), Application (Aesthetic Use, Therapeutics Use), End User (Clinics) Players and Region - Global Market Outlook to 202...
$ 3500
Ampoules Packaging Comprehensive Study by Type (Polyvinyl Chloride, Polyethylene Terephthalate, High Impact Polystyrene), Application (Pharmaceuticals, Personal Care, Chemical, Others), Category (Gla...
$ 3800
Wound Care Dressing Comprehensive Study by Type (Hydrocolloid, Hydrogel, Alginate, Collagen, Others), Application (Acute wounds, Chronic Wounds, Surgical Wounds) Players and Region - Global Market Ou...
$ 3500
Intravenous Iron Drugs Comprehensive Study by Type (Ferric Gluconate, Ferric Carboxyl Maltose, Iron Sucrose, Iron Dextran), Application (Adult, Paediatric), Distribution Channel (Hospital Pharmacies,...
$ 3650
Calcium Tablets Comprehensive Study by Type (Effervescent Tablets, Chewable Tablets, Sublingual Tablets, Enteric Coated Tablets), Purchase Pattern (OTC, Prescription), Distribution Channel (Retail Ph...
$ 3650
Human Rotavirus Vaccine Comprehensive Study by Type (Rotarix, Rotavac, Rotavin-M1, Lanzhou Lamb, Others), Application (Hospitals, Clinics, Academic and Research, Others), Distribution Channel (Hospit...
$ 3350